Its that time of the month for HCV Advocates informative hepatitis C newsletter. I always look forward to reading the updates provided by the devoted team of authors, and staff. Check out the topics of this months newsletter below.
I'm a bit late bringing this to you, but two months ago ABC News interviewed Dr. David Agus, the author of "The End of Illness,". In the book Dr. Agus points out minor signs in the skin, nails, hair and even finger length, which may offer clues to an individuals overall health, interesting? Watch the video along with the article from ABC news below.
Another "healthy you" article on the blog today is from Medscape, which answers this question: Does Coffee Really Protect Against Liver Fibrosis ?
And finally a video on treating hepatitis C with the FDA approved drug Incivek.
I love pointing my readers to personal blogs written by either caregivers or brave people battling this disease. If you haven't read these special blogs, I hope you consider taking a stroll over to find out whats new.
by Alan Franciscus—read about the recommendations for use of the Victrelis (boceprevir) and Incivek (telaprevir) plus PEG/RBV triple therapies for treating chronic hepatitis C in people who are also infected with HIV. Included in this article is important information about the drug-drug interactions between HIV medications and the new HCV protease inhibitors.
by Lucinda Porter, RN, and Alan Franciscus—in this month’s column we write about HCV and the brain, treating HCV patients who drink alcohol, combination therapy with daclatasvir/asunaprevir plus PEG/RBV, increase in liver cancer rates, the benefits of Vitamin D, ‘normal’ ALT levels, and the risk of transmitting HCV through tattooing and piercing.
New HCSP Fact Sheet series – we have updated information and reformatted some of our fact sheets. Check out the Extrahepatic Manifestations sectionand some other fact sheets that have been recently revised and reformatted.
by Christine Kukka—This month’s review features important news and journal articles—how HBV and HCV deaths have surpassed HIV deaths, treating immune-tolerant hepatitis B, the benefits of incorporating fish and fatty acids into the diet to help decrease the risk of liver cancer, the protective effects of estrogen, and much, much more.
Can seemingly trivial details such as the length of your fingers and whether you wear high heels actually be important clues about your risk for serious medical conditions?
According to Dr. David Agus, author of the new book "The End of Illness," finger length and shoe type are two potentially important pieces of information people can use to unlock their body's secret code. By learning to interpret the body's signals, Agus says people can prolong their health and live their lives free of illness.
"The end of illness is closer than you might think," Agus, also a professor of medicine at the University of Southern California Keck School of Medicine, wrote in the introduction to his book. But to achieve that, he continued, people must look at their bodies in a whole new way.
"Medicine today is, 'I treat the individual condition. Your joint hurts, I'll give you something to help the joints.' But I want to figure out why. What in your system allowed that joint to hurt. And I want to change the whole system in a different direction," Agus told ABC News.
In the book, Agus offers much medical advice he believes people should carefully consider, and there are many recommendations on gathering information that may never have seemed important before, such as the color of the fingernails. While patients should not consider these indicators definitive indicators of illness, he said taking note of them may help patients and their doctors determine next steps in terms of diagnostic tests.
"All these tickers, I want all that data put together before you go to your doctor," he said.
Some of the tips, he says, may seem contrary to what the medical establishment has long recommended, but are important because they show how every part of the body plays a role in maintaining good health. For example, he talks about what it could mean if unpolished nails are a certain color or if people notice they are losing hair near their ankles.
Not all agree that these indicators are always relevant. Doctors in preventive medicine who were not involved in writing Agus' book say while some of the advice he offers is thought-provoking, current scientific evidence suggests these risk factors may not be issues upon which people should necessarily focus.
Still, Agus, who has garnered numerous accolades and is widely know as a cutting-edge figure in medicine, said these seemingly minor signs may offer clues to overall health. On the following pages are some of Agus' hidden health indicators he said people need to be aware of, and how medical experts weigh in.
Finger Length
"If you're a woman, and, for example, you look at your ring finger and index finger, there's data," Agus told ABC News. "And this is a real published study showing that if your ring finger is bigger than your index finger, you're almost twice as likely to get osteoarthritis."
In the book, Agus cited a 2008 study in the journal Arthritis & Rheumatism that found an association between longer ring fingers and higher testosterone exposure in the womb, which lowers the levels of estrogen, a hormone critical to bone development.
In men, Agus wrote that the pattern is reversed -- if the index finger is longer than the ring finger, the risk of developing prostate cancer drops by a third.
The issue of finger length has been a subject of study in the past. A sub-study of the very large and well-known Framingham Heart Study did find a difference in finger length among women with osteoarthritis, and researchers said that arthritis could account for the length discrepancy.
Some experts say that this means a person already has osteoarthritis, not that a person is going to get it. Dr. Sharon Bergquist, assistant professor of medicine at the Emory University School of Medicine in Atlanta, said there have been a number of studies that found a link between finger length and the condition, but the data do not suggest having a longer index finger causes osteoarthritis.
"Even if there is an association, what does it imply from a preventive standpoint, because you can't change the length of your fingers," she said.
But she added that if there are well-established factors present for osteoarthritis, such as being older, being a woman, being sedentary and having other conditions such as gout, an underactive thyroid or diabetes, people can make lifestyle changes such as building up muscle and maintaining proper posture that can prevent the disease from happening in the first place.
Nails
Although nails often get attention only as part of a beauty regimen, Agus said they can hold vital health clues.
"Discolored nails can signal certain conditions, from a simple infection to diabetes," he wrote. "If your nails have a yellowish hue to them, it's time for a diabetes check."
Previous research has found diabetes can cause yellowish nails, possibly due to diabetics' inability to properly break down sugar. Thus, the finding of yellowed nails could be a clue that testing for diabetes is in order.
But those with yellow nails must bear in mind that this does not necessarily mean they have diabetes.
"I know many people with diabetes that have normal-colored nails, and people with yellowish nails that don't have diabetes," said Dr. Robert Schwartz, chair of the Department of Family Medicine and Community Health at the University of Miami's Miller School of Medicine.
Nails can become yellow because of other conditions, such as lung disease or heart disease, which cause a lack of circulation to the extremities, fungal infections and age. As people age, the nails can get thicker and grow slower, leading to a susceptibilitiy to fungal infections. Many smokers also have yellowed nails.
Agus also notes a lack of the white crescent normally present above the cuticle can signal a problem with low iron levels.
Hair
Hair is another part of the body that can harbor hidden health signs. Graying and baldness can certainly indicate aging, but what about finding hair where it's never been before, or losing hair in previously unnoticed places?
"Have you lost hair around your ankles? This could be a sign of a circulatory problem, especially noticeable in men," Agus wrote.
Circulatory problems can indeed cause men and women to lose hair around their feet and lower legs. But those concerned about unusual hair loss should also be aware that it could also be due to something else.
"In men, most of the time they're wearing very tight socks that can cause hair loss," Scwartz said.
According to the National Institutes of Health, excessive hair growth, known as hirsutism, can indicate a medical issue, but it often has no cause at all and can be hereditary.
But it can also be a result of a hormonal imbalance. Women, Agus said, often start growing hair on their face or arms, which could mean hormonal changes.
Polycystic ovary syndrome, caused by multiple cysts in the ovaries that lead to an excess of male hormones, is one cause. Cushing's syndrome, characterized by an excess of cortisol that causes a sex hormone imbalance, is another possible cause. Obesity, tumors and certain medications can also cause hirsutism.
Shoes
Women who favor high heels have probably noticed how much their feet and legs hurt after a long day of wearing them, but Agus says the risk to women is much greater than aching feet.
"Aching feet means inflammation. Inflammation in the long term is bad for heart disease, for cancer, for neural degenerative diseases. We want to prevent inflammation," Agus said, calling heels and platform pumps "hidden, sneaky sources of chronic inflammation."
The idea that uncomfortable shoes could lead to problems beyond strained muscles and joints is a controversial one.
"Chronic inflammation can affect the heart. It can lead to an increase of C-reactive protein that is associated with heart disease, but this isn't necessarily caused by wearing high heels," said Schwartz.
"High heels definitely pose more of an issue with the musculosketal system," said Bergquist.
Sitting
According to Agus, too much sitting can be just as unhealthy as smoking.
"Researchers at the American Cancer Society released a study published in 2010 in the American Journal of Epidemiology that pretty much said sitting down for extended periods poses a health risk as 'insidious' as smoking or overexposure to the sun," Agus wrote.
He cited one study that found women who reported sitting for more than six hours a day outside of work were 37 percent more likely to die than those who sat less than three hours a day. Other research, he added, has linked sitting to obesity, type 2 diabetes, cardiovascular disease and an unhealthy diet.
It's not so much the sitting, he explained, it's the physiological processes sitting causes that are the big culprits.
Even if people exercise once a day, sitting too much can cause increased blood sugar, higher blood pressure and higher triglyceride levels, all linked to cardiovascular disease, obesity and other chronic problems.
And the negative health impacts of sitting is a topic on which many health experts agree.
"The lack of physical activity is the root cause of many diseases," said Bergquist. "It's important to be active and continually move."
I heard a report that coffee may protect against liver fibrosis in patients with fatty liver disease -- is it true?
Response from William F. Balistreri, MD
Professor of Medicine, University of Cincinnati College of Medicine; Staff Physician, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Coffee and Fatty Liver Disease
That report likely refers to a recent study in which investigators attempted to correlate coffee (caffeine) consumption with the severity of nonalcoholic fatty liver disease (NAFLD).[1] As Malloy and colleagues point out, an association between coffee consumption and a reduced risk for liver disease progression was established years ago.[2-5] Coffee intake has been shown to correlate with lower liver enzyme levels and a reduced risk for hospitalizations and mortality in patients with cirrhosis. A recent example: Coffee consumption was linked to lower rates of clinical and pathologic progression of liver fibrosis in patients with chronic hepatitis C infection.[6]
Investigators at Brooke Army Medical Center in Fort Sam Houston, Texas,[1] therefore, questioned whether coffee ingestion by patients with NAFLD would similarly slow the progression of liver disease from steatosis to nonalcoholic steatosis (NASH). In their study, more than 300 patients underwent liver ultrasound; those in whom the ultrasound was negative for fatty liver served as controls. Patients with steatosis suggested by ultrasound underwent liver biopsies to categorize the patients into 3 groups:
Bland steatosis without evidence of NASH;
NASH with stage 0-1 fibrosis; and
NASH with stage 2-4 fibrosis.
A validated questionnaire was used to determine whether a relationship existed between caffeine consumption (assessing the average mgs of total caffeine/coffee per day) and the degree of steatosis/NASH. A negative relationship was found between caffeine/coffee consumption and the degree of hepatic fibrosis. A significant difference in caffeine/coffee consumption was found between patients who had bland steatosis compared with those who had NASH stage 0-1, as well as between patients who had NASH stage 0-1 compared with those who had NASH stage 2-4. Therefore, this study demonstrates a histopathologic correlation between progression of fatty liver disease and estimated coffee intake. In their cohort of patients with NASH, increased intake of coffee seemed to confer a significantly reduced risk for advanced fibrosis. What is not clear from their data is the amount of coffee or caffeine that must be ingested to lower the risk for fibrosis. Also, because the study was not prospective, the impact of the observed effects on clinical outcomes over time is unknown. Further prospective studies are required.
What Is the Mechanism?
Assuming that the beneficial effects are real, what is the mechanism? Does coffee intake have a direct effect -- attributable to caffeine or to "magical powers of the bean"? Or is the effect indirect -- related to the preferential intake of coffee as a substitute for high-calorie, high-fructose-containing beverages? The investigators point out that the effects may be "more than strictly related to caffeine’s antioxidant behaviors." They cite a study in which rats receiving a high-fat diet given decaffeinated coffee had lower levels of hepatic fat and collagen, reduced liver oxidative stress (an effect of glutathione metabolism), and less liver inflammation -- emphasizing the likely importance of coffee itself, not caffeine, in preventing the progression of NASH. Potential beneficial components include aromatic extracts isolated from coffee beans and/or an elevation of glutathione levels or other antifibrogenic agents by coffee intake.[7-9]
The Bottom Line
What advice can we offer to patients with fatty liver disease? Despite the preliminary results about the beneficial effects of vitamin E and omega-3 fatty acids, lifestyle changes (ie, weight loss through diet and exercise) are the only strategies proven to be effective.[10,11] Moderate consumption of coffee may be a useful, benign adjunct -- but hold the cream and sugar!
DDW 2012 Clinicians, researchers and scientists from around the world will gather for Digestive Disease Week® (DDW) 2012, the largest and most prestigious gastroenterology meeting, from May 19-22, 2012, at the San Diego Convention Center, CA. DDW, the annual meeting of the American Gastroenterological Association (AGA) Institute, is jointly sponsored by the American Association for the Study of Liver Diseases, the AGA, the American Society for Gastrointestinal Endoscopy and the Society for Surgery of the Alimentary Tract. Click here for updates
May 18-2012 U.S. health officials want all baby boomers to get tested for hepatitis C. The Centers for Disease Control and Prevention on Friday released draft recommendations calling for all baby boomers to get a one-time blood test for the liver disease. That's everyone born from 1945 to 1965. CDC - Draft Recommendations
Find Hepatitis Testing Year Round Near You Locate organizations offering Hepatitis testing and additional services vaccines and treatment in the NPIN Organizations Database.
A special supplementary issue of Gastroenterology with full text viral hepatitis review articles and commentaries available through open access. Click here to view an index of articles.
A Few Topics Include; Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus
Will Interferon-Free Regimens Prevail?
Books Free from Hepatitis C About the Author Lucinda K. Porter, RN is an active hepatitis C advocate who writes, teaches, and lectures on the topic. She is recognized as a leader in her field based upon her professional experience and her first hand knowledge of living with the disease.
Ms. Porter has been a research nurse at Stanford University Medical Center specializing in HCV and her articles and guides have appeared in numerous HCV newsletters and journals.
Today, in addition to being a highly sought-after speaker, she continues to work with various HCV groups on behalf of patients and their families
Alisporivir-Three cases of acute pancreatitis, one fatal, have led the FDA to put a clinical hold on a trial of an investigational oral drug for hepatitis C called alisporivir, according to the product's manufacturer.
Projects In Knowledge Offered at the site is a program series of HCV Video Case Vignettes.In the videos individual patient case studies are discussed, topics include side effects, drug-drug interactions, treatment duration, and outcome.
AASLD - Liver Learning If you haven't yet explored the "Liver Learning" section available @ the AASLD web site you're missing out on the November meeting webcasts, video podcasts, abstracts and more.
2012 March 2012-New Antiviral Agents for Hepatitis C This article describes the direct acting antivirals and host-targeted agents that have recently been approved or have been tested in HCV-infected patients and discusses their two current paths of clinical development: with or without interferon-α.
Protease inhibitors: Silver bullets for chronic hepatitis C infection? Recent trials evaluated the safety and efficacy of two protease inhibitors, boceprevir (Victrelis) and telaprevir (Incivek), added to standard care with pegylated interferon and ribavirin, in patients with chronic hepatitis C virus (HCV) infection. These drugs open the door for triple therapy and other new therapies involving combinations of other direct-acting antiviral agents to become the new standard of care for this population.
Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir A significant increase in the number of patients with CHC to be treated is expected for 2012, with triple therapy regimens that are more complex. These expected developments represent a significant challenge and will stretch current resources. The present Swiss Association for the Study of the Liver (SASL) expert opinion statement is not intended as guideline but shall provide some guidance on the management of CHC genotype 1 and the use of TPV and BOC
By joining networked blogs readers will be able to view all blog updates as they appear on the blog. *The majority of HCV news, research and updates are not posted on this blogs facebook page.
Clinical Trials-
To learn more about Hepatitis C virus clinical trials or to find out if a study is enrolling patients in your area, please click here.
Hepatitis C-New Protease Inhibitor (NS3/4A) Drug Resistance Test LabCorp has begun offering nationwide its hepatitis C GenoSure NS3/4A assay, which is designed to identify NS3 and NS4A mutations and NS3-associated resistance to a pair of recently approved HCV protease inhibitors.
Multimedia-Videos and Podcasts
Can't Find What You're Looking For? Click On A Topic Below
SUPPORT A new national toll-free helpline has been launched for people affected by hepatitis C: 877-HELP-4-HEP (877-435-7443).
This new consumer-run helpline is staffed by specially trained peer counselors Monday through Friday, 9am to 7pm EST to provide emotional support, health information, and referrals.
HELP-4-HEP is a partnership among several well-known and nationally recognized nonprofits with a combined 90+ years’ experience in hepatitis C education, support and patient advocacy.
Click here to order a FREE Home Access Hepatitis C Test Kit
How Soon Should I Get Tested After Exposure ?
After the exposure (especially if the blood exposure involved another person known to have the hepatitis C virus), it is recommended that testing for the hepatitis C antibody be performed at 4 to 6 months after the exposure OR that testing for the hepatitis C virus itself (a test often called an HCV PCR or hepatitis C viral load test) be performed 4 to 6 weeks after the potential exposure. These tests are done to determine whether or not hepatitis C infection has occurred as a result of the exposure.;
FAIR USE NOTICE:
If this site contains copyrighted material the use of which has not been specifically authorized by the copyright owner, it is being made available in an effort to advance the understanding of the ethics dealing with medical practice, medical care, new drug research, drug trials, science and scientific research, human rights, social justice and, in addition, the law and politics which cover these areas. It is believed that this use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed to visitors of this “HCV New Drugs Blog” without profit to the blog or to those who by visiting this blog have expressed interest in receiving the included information for research and educational purposes. The material in this site is provided for educational and informational purposes only, and is not intended to be a substitute for a health care provider's consultation. Please consult your own appropriate health care provider about the applicability of any opinions or recommendations with respect to your own symptoms or medical conditions. The information on this site does not constitute legal or technical advice
Keeping current on the potential arrival of new, improved Hepatitis C drugs is a regular research venture for many who are living with the Hepatitis C virus.
I was 43, a mother of three when I found out I had HCV. I went on to be treated successfully in 2000.(Intron A/Riba).
Only people who have experienced a chronic illness understand the fear and apprehension felt with each step up the ladder, climbing closer to either medical treatment or a possible cure. These millions of people (I was one of them) who are living with chronic hepatitis C or just newly diagnosed are often left out in the cold, alone, with many unanswered questions. Enter the sleepless nights, anxiety, waking each day wondering what to do next.
My blog is here to help you learn about HCV, the new drugs to treat this disease along with news and updates.
Wishing you all a safe journey.
Tina
0 comments: